Hepatoselectivity and the evolution of insulin

A Randomized, Controlled Study of Once-Daily LY2605541, a Novel Long-Acting Basal Insulin, Versus Insulin Glargine in Basal Insulin-Treated Patients With Type 2 Diabetes

(2012) R. M. Bergenstal et al.   DIABETES CARE

Insulin Degludec in Type 1 Diabetes: A randomized controlled trial of a new-generation ultra-long-acting insulin compared with insulin glargine

(2011) K. I. Birkeland et al.   DIABETES CARE

Insulin Detemir Reduces Weight Gain as a Result of Reduced Food Intake in Patients With Type 1 Diabetes

(2011) S. Zachariah et al.   DIABETES CARE

Structural Basis of the Aberrant Receptor Binding Properties of Hagfish and Lamprey Insulins

(2009) Waseem Sajid et al.   BIOCHEMISTRY

Improved Glycemic Control With Intraperitoneal Versus Subcutaneous Insulin in Type 1 Diabetes: A randomized controlled trial

(2009) S. J. Logtenberg et al.   DIABETES CARE

Where Does Insulin Resistance Start?: The brain

(2009) U. Pagotto   DIABETES CARE

Differential effects of insulin detemir and neutral protamine Hagedorn (NPH) insulin on hepatic glucose production and peripheral glucose uptake during hypoglycaemia in type 1 diabetes

(2009) F. Smeeton et al.   DIABETOLOGIA